This partnership aims to increase decision-making confidence, accelerate programs toward clinical milestones, and reduce R&D costs. Financial terms were not disclosed. The parties will jointly own the ...
Acute myeloid leukaemia (AML) is mainly characterized by an increase in the number of myeloid cells in the bone marrow and a decrease in mature cells, accounting for 28% of leukaemia cases, with a ...
Efficacy of third-line and later (3L+) therapies post poly (ADP-ribose) polymerase inhibitor (PARPi) exposure in recurrent platinum-sensitive ovarian cancer (PSOC): A pooled clinical trial database ...
Novigenix, a leader in AI-driven healthcare solutions, has published a groundbreaking study showcasing the predictive power of its LITOSeek ™ platform for immunotherapy response in metastatic ...
OXFORD, Oxfordshire, UK, 14 October 2025 -- In a compelling Genomic Press Interview published today in Genomic Psychiatry, Dr. Najaf Amin unveils transformative insights that fundamentally reshape ...
Heng et al. apply a multi-omics approach combining analyses of energy metabolism, immune cell composition, and plasma proteomics. They reveal altered energy metabolism and immune profiles, alongside ...
Vizgen, Inc., a leader in spatial multi-omics at single-cell resolution, today announced a series of innovations under development to help accelerate drug discovery, advance understanding of disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results